NCT03967808

Brief Summary

The Renal Epidemiology and Information Network (REIN) Registry was created in 2002 (after study pilot in 2001) to contribute to the development and evaluation of health strategies aiming at improving prevention and management of end-stage renal disease, and promoting clinical and epidemiological research in this field. It relies on a network of nephrologists, epidemiologists, patients and public health representatives, coordinated regionally and nationally.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
6,000

participants targeted

Target at P75+ for all trials

Timeline
296mo left

Started Jan 2001

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress51%
Jan 2001Dec 2050

Study Start

First participant enrolled

January 1, 2001

Completed
18.4 years until next milestone

First Submitted

Initial submission to the registry

May 27, 2019

Completed
3 days until next milestone

First Posted

Study publicly available on registry

May 30, 2019

Completed
31.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2050

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2050

Last Updated

July 28, 2021

Status Verified

July 1, 2021

Enrollment Period

49.9 years

First QC Date

May 27, 2019

Last Update Submit

July 27, 2021

Conditions

Keywords

RegistryRenal replacement therapy

Outcome Measures

Primary Outcomes (1)

  • Occurence of end stage renal disease in Renal Replacement therapy

    New (incident) patients are reported from the first day of Renal Replacement Therapy - either dialysis or renal transplantation

    One year

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All new patients reaching end-stage chronic renal failure and requiring support by a renal replacement therapy

You may qualify if:

  • All patients with end stage renal disease on renal replacement therapy

You may not qualify if:

  • Patients with acute renal failure ( i.e. those who recover all or some renal function within 45 days or are considered as such by experts when they die before 45 days)
  • Patient's refusal

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Nephrology unit, University hospital

Nancy, 54000, France

RECRUITING

Related Publications (2)

  • Lassalle M, Ayav C, Frimat L, Jacquelinet C, Couchoud C; Au Nom du Registre REIN. The essential of 2012 results from the French Renal Epidemiology and Information Network (REIN) ESRD registry. Nephrol Ther. 2015 Apr;11(2):78-87. doi: 10.1016/j.nephro.2014.08.002. Epub 2014 Nov 1.

    PMID: 25457107BACKGROUND
  • Couchoud C, Stengel B, Landais P, Aldigier JC, de Cornelissen F, Dabot C, Maheut H, Joyeux V, Kessler M, Labeeuw M, Isnard H, Jacquelinet C. The renal epidemiology and information network (REIN): a new registry for end-stage renal disease in France. Nephrol Dial Transplant. 2006 Feb;21(2):411-8. doi: 10.1093/ndt/gfi198. Epub 2005 Oct 18.

    PMID: 16234286BACKGROUND

MeSH Terms

Conditions

Kidney Failure, Chronic

Condition Hierarchy (Ancestors)

Renal Insufficiency, ChronicRenal InsufficiencyKidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Emmanuelle Laurain, MD

    Central Hospital, Nancy, France

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Carole Ayav, MD

CONTACT

Francis Guillemin, MD,PhD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
30 Years
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Doctor

Study Record Dates

First Submitted

May 27, 2019

First Posted

May 30, 2019

Study Start

January 1, 2001

Primary Completion (Estimated)

December 1, 2050

Study Completion (Estimated)

December 1, 2050

Last Updated

July 28, 2021

Record last verified: 2021-07

Locations